Clinical trials in Roskilde – page 45

1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Roskilde at a glance

1 178

clinical trials

Research sites3

Quick filters

1 178 trials in Roskilde

Open in trial search

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Norwegian University Of Science And Technolology

Contact Research Centre

Anorexia nervosa

Not yet recruiting

Dry extract from Psilocybe cubensis (15‑25:1) with methanol for adults with treatment‑resistant anorexia nervosa: a randomized, active‑placebo, triple‑blind trial

InvestigationalNo placebo

Dry extract from Psilocybe cubensis (15‑25:1) with methanol for adults with treatment‑resistant anorexia nervosa: a randomized, active‑placebo, triple‑blind trial

InvestigationalNo placebo

Denmark

Participants:18–64 years
Sponsor:Slagelse Hospital

Contact Research Centre

Labour induction

Not yet recruiting

Oral sodium hydrogen carbonate versus placebo to reduce assisted delivery in nulliparous women with prolonged labour

Registered drug

Oral sodium hydrogen carbonate versus placebo to reduce assisted delivery in nulliparous women with prolonged labour

Registered drug

Denmark

Participants:18–64 years
Substances:Sodium Hydrogen Carbonate
Sponsor:Region Hovedstaden

Contact Research Centre

Transitional cell carcinoma

Not yet recruiting

Phase Ib/II Study of LP-184 in Patients with Advanced or Metastatic Urothelial Carcinoma

InvestigationalNo placebo

Phase Ib/II Study of LP-184 in Patients with Advanced or Metastatic Urothelial Carcinoma

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Zirdafulven
Sponsor:Region Hovedstaden

Contact Research Centre

Sedative therapy

Not yet recruiting

Patient‑controlled remimazolam, alfentanil and midazolam sedation for outpatients undergoing colonoscopy: safety, efficacy and satisfaction study

Registered drugNo placebo

Patient‑controlled remimazolam, alfentanil and midazolam sedation for outpatients undergoing colonoscopy: safety, efficacy and satisfaction study

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Alfentanil
Sponsor:Region Hovedstaden

Contact Research Centre

Depression

Not yet recruiting

Effect of dry extract from Psilocybe cubensis (15‑25:1), extraction solvent methanol, with psychotherapy versus basic support on depressive symptoms in adults with depression

InvestigationalNo placebo

Effect of dry extract from Psilocybe cubensis (15‑25:1), extraction solvent methanol, with psychotherapy versus basic support on depressive symptoms in adults with depression

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Sponsor:Koebenhavns Universitet

Contact Research Centre

Major depression

Not yet recruiting

Effect of Stopping Ethinylestradiol/Levonorgestrel Contraceptive on Mood and Memory in Adults with Major Depressive Disorder on Antidepressant Combination

Registered drug

Effect of Stopping Ethinylestradiol/Levonorgestrel Contraceptive on Mood and Memory in Adults with Major Depressive Disorder on Antidepressant Combination

Registered drug

Denmark

Participants:18–64 years
Substances:Duloxetine
Sponsor:Region Hovedstaden

Contact Research Centre

Cardiovascular disorder

Not yet recruiting

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug

Denmark

Participants:18–64 years · 65+ years
Sponsor:Copenhagen University Hospital

Contact Research Centre

Parkinson's disease

Not yet recruiting

Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

Registered drugNo placebo

Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Levodopa
Sponsor:Region Hovedstaden

Contact Research Centre

Plasma cell myeloma refractory+1

Not yet recruiting

Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

Registered drugNo placebo

Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Region Hovedstaden

Contact Research Centre

Interstitial lung disease+2

Not yet recruiting

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Admilparant
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Muscular dystrophy

Not yet recruiting

Long-Term Safety and Efficacy of Oral Ribitol in Participants with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I/R9)

InvestigationalNo placebo

Long-Term Safety and Efficacy of Oral Ribitol in Participants with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I/R9)

InvestigationalNo placebo

Denmark

Participants:18–64 years
Substances:Ribitol
Sponsor:ML Bio Solutions Inc.

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Roskilde

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.

Advanced cancer therapies
Immunotherapy combinations
Molecular response studies

Ongoing investigations into personalized treatment approaches for various cancer types.

02 Cardiovascular Studies

Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.

Prevention strategies
Risk reduction therapies
Innovative drug combinations

Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.

03 Immunology and Dermatology

Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.

Inflammatory skin conditions
Novel biological therapies
Treatment efficacy studies

Advancing treatment options for patients with moderate to severe skin conditions.

04 Infectious Disease Research

Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.

Vaccine development
Immunogenicity studies
Prevention strategies

Important research advancing preventive medicine and infection control.

Back to Denmark All countries